Akiko Tanaka
Vascular Surgery · Houston, TXNPI 1174917306
Payments from drug & device makers
Across 182 payments — averaging $128.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$6K
- Edwards Lifesciences$3K
- W. L. Gore & Associates, Inc.$3K
- Penumbra, Inc.$2K
- Medtronic$2K
- Silk Road Medical, Inc.$2K
- plus $5K from 18 others
What the payments were for
- Travel & lodging$7,89834%
- Food & beverage$15,48166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 32 | $5,799 |
| Edwards Lifesciences | 21 | $2,979 |
| W. L. Gore & Associates, Inc. | 30 | $2,826 |
| Penumbra, Inc. | 8 | $2,289 |
| Medtronic | 21 | $2,280 |
| Silk Road Medical, Inc. | 16 | $1,740 |
| Atricure, Inc. | 10 | $1,344 |
| Cook Medical LLC | 10 | $948 |
| Endologix LLC | 7 | $586 |
| Davol Inc. | 4 | $372 |
| Abbott | 5 | $330 |
| Artivion, Inc. | 3 | $320 |
| Medinc Of Texas | 2 | $241 |
| Limflow Inc. | 1 | $225 |
| Abiomed | 1 | $152 |
| Baxter Healthcare | 1 | $147 |
| Amgen | 2 | $142 |
| Inari Medical, Inc. | 2 | $139 |
| Bard Peripheral Vascular, Inc. | 1 | $133 |
| Bolton Medical Inc | 1 | $124 |
| Lemaitre Vascular, Inc. | 1 | $110 |
| Sanara Medtech Inc. | 1 | $100 |
| Johnson & Johnson | 1 | $26 |
| Imperative Care, Inc | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AngioVac$3,827
- Indigo System$2,197
- ENROUTE Transcarotid Neuroprotection System$1,682
- ENROUTE Transcarotid Stent$1,533
- MITRIS RESILIA Mitral Valve$1,450
- AlphaVac$1,214
- GORE TAG Thoracic Branch Endoprosthesis$698
- SYNERGY ABLATION SYSTEM$657
- GORE TAG Thoracic Endoprosthesis$656
- COREVALVE EVOLUT R$626
- Abre$421
- Cook$377
- ENDURANT IIS$373
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$344
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$272
- GORE EXCLUDER AAA Endoprosthesis$258
- Torus Stent Graft System$252
- ENDOCROSS Device$252
- Alto Abdominal Stent Graft System$244
- LIMFLOW SYSTEM$225
How this compares
$23,379 in reported general payments places this provider in the 75th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $10,810 |
| ClopidogrelClopidogrel Bisulfate | 18 | $73 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Houston
- Alan LumsdenHouston$2.4M
- Gustavo OderichHouston$999K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
- Jean BismuthHouston$382K
- Kristofer Charlton-OuwHouston$240K
- Maham RahimiHouston$221K
- Jayer ChungHouston$179K
- Steven MaximusHouston$140K
- Charudatta BavareHouston$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.